Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Hepatic Impairment

NCT04145596 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: HSK3486

Sponsor

Sichuan Haisco Pharmaceutical Group Co., Ltd

Collaborators

[object Object]